$0.57 0.4%
XAIR Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Beyond Air

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system.


Beyond Air
Price $0.57
Target Price Sign up
Volume 606,330
Market Cap $26M
Year Range $0.54 - $2.17
Dividend Yield 0%
Revenue per Employee $12,900
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '23390,000750,000-360,000-16M-16M-0.500
Q3 '23240,000430,000-190,000-16M-17M-0.510
Q2 '2359,000300,000-240,000-14M-16M-0.450
Q1 '23210,000310,000-310,000-20M-14M-0.670
Q4 '22240,00068,000-68,000-13M-14M-0.430

Insider Transactions View All

Avniel Amir filed to sell 685,760 shares at $2.1.
December 29 '23
Myers Jeff Lynn filed to sell 46,577 shares at $2.2.
December 29 '23
Lisi Steven A. filed to buy 1,536,471 shares at $1.6.
December 19 '23
Carey Robert filed to buy 2,374,454 shares at $1.6.
December 19 '23

What is the Market Cap of Beyond Air?

The Market Cap of Beyond Air is $26M.

How Many People Work at Beyond Air?

As of our latest update, Beyond Air employed approximately 70 people worldwide. However, it's important to note that Beyond Air's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Beyond Air's revenue per employee?

$12,900. To calculate Beyond Air's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Beyond Air?

Currently, the price of one share of Beyond Air stock is $0.57.

How can I analyze the XAIR stock price chart for investment decisions?

The XAIR stock price chart above provides a comprehensive visual representation of Beyond Air's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Beyond Air shares. Our platform offers an up-to-date XAIR stock price chart, along with technical data analysis and alternative data insights.

Does XAIR offer dividends to its shareholders?

As of our latest update, Beyond Air (XAIR) does not offer dividends to its shareholders. Investors interested in Beyond Air should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Beyond Air?

Some of the similar stocks of Beyond Air are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.